Abstract. A single injection of 1500 IU of human chorionic gonadotrophin (hCG) in normal men, induced a block in the conversion of 17-hydroxyprogesterone (17-OHP) to testosterone (T) which reached its maximum 24 h after hCG loading. One week after hCG administration both basal 17-OHP (3.8 \m=+-\0.6 vs 5.1 \m=+-\0.5 nmol/l, P < 0.02) and T levels (15.1 \m=+-\1.7 vs 18.5 \m=+-\2.3 nmol/l, P < 0.05) were about 20% lower than before hCG exposure. The ratio 17-OHP to T (0.29 \ m=+-\0.04 vs 0.31 \ m=+-\ 0.04, P > 0.10) was however similar, suggesting recovery from the prior 17,20-lyase suppression at a lower overall capacity of T synthesis. hCG administration one week after the priming dose elicited an increase in the ratio 17-OHP to T, which was about twice as high as after the first hCG injection. Together the data suggest: 1) suppression of testicular steroidogenesis proximal to 17-OHP one week after hCG priming, 2) enhanced hCG induced 17,20-lyase suppression one week after hCG exposure.
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Administration of a single dose of human chorionic gonadotrophin (hCG) Forest et al. 1979; Smals et al. 1980a,b,c; Wang et al. 1980 ). This inappropriate rise of 17-OHP has been attributed to oestrogen (?) mediated suppression of 17,20-lyase enzymatic ac¬ tivity (Smals et al. 1980c,d; Cigorraga et al. 1980 ).
Return of the 17-OHP/T ratio to pre-treatment levels or even lower (Smals et al. 1980a,b) (Smals et al. 1976 (Smals et al. , 1978 . The intra-assay coefficients of variation were 4 and 6.1%, respectively. To avoid inter-assay variation all samples from one subject were measured in the same assay.
Statistical analysis was performed using Student's paired ¿-test. The mean values ± 1 sem are given.
Results
Basal 17-0HP and T levels and the ratio 17-OHP to T before the first and second hCG injection ( Fig. 1) The mean basal 17-OHP and T levels immediately before the second injection of hCG were signifi¬ cantly lower than before the priming dose (3.8 ± 0.6 vs 5.1 ± 0.5 nmol/1, P < 0.02 and 15.1 ± 1.7 vs 18.5 ± 2.3 nmol/1, P < 0.05), but the mean ratio of 17-OHP to T was similar (0.29 ± 0.04 vs 0.31 ± 0.04,P>0.I0).
Effect of two separate hCG injections on 17-OHP, T and the ratio of 17-OHP to T (Figs. 1 and 2) Single hCG administration increased 17-OHP levels at 24, 48 and 72 h after the first injections to 2.1 ±0.2 (P< 0.001), 1.9 ±0.2 (P< 0.001) and 1.5 ± 0.2 (P < 0.001) times the baseline value, respectively, whereas T levels rose to 1.5 ±0.1 (P< 0.001), 1.7 ±0.1 (P< 0.001) and 1.8 ± 0.2 (P < 0.01) times the pre-treatment level. Thus be¬ tween 24 and 72 h after hCG injection 17-OHP and T ran a dissociated course with T rising and 17-OHP falling. A transient accumulation of 17-OHP relative to T as refelcted by an elevated 17-OHP/T ratio, 1.5 ±0.1 times baseline (P < 0.001 vs t = 0) was noted at 24 h. Thereafter the ratio decreased to 1.1 ± 0.1 at 48 h (P > 0.10 vs t = 0) and 0.8 ± 0.1 at 72 h (P > 0.10 vs t = 0).
Before the second hCG injection the mean basal 17-OHP and T levels were significantly lower than before the priming dose. As in the first experiment maximum 17-OHP levels were achieved 24 h after the second injection of hCG (10.2 ± 0.9 ng/100 ml vs 10.0 ± 0.7 nmol/1). Although the absolute maxi¬ mum increase of 17-OHP tended to be higher after the second injection (6.8 ± 0.9 vs 5.2 ± 0.7 nmol/1) the difference was not statistically significant (0.05 < P < 0.10). The mean relative increase of 17-OHP after the second hCG injection however was significantly higher than after the priming dose (3.4 ± 0.6 vs 2.1+ 0.2 times baseline, P < 0.025). As in the first experiment maximum plasma T levels were achieved 72 h after the second injection. Although the mean T levels achieved 24, 48 and 72 h after the second injection of hCG remained significantly lower than in the first experiment (20.6 ± 1.9 vs 26.2 ± 2.2 nmol/1 at 24 h, P < 0.01, 26.0 ± 2.5 vs 31.7 ± 2.6 nmol/1 at 48 h, P < 0.02 and 26.1 ± 2.6 vs 32.4 ± 2.7 nmol/1 at 72 h, P < 0.01) the mean maximum absolute (12.2 ± 2.0 vs 15.0 ± 1.7 nmol/1) and relative 81.9 ± 0.1 vs 1.9 ± 0.2) increments were of the same order of magni¬ tude (P > 0.10). Despite almost similar basal 17-OHP to T ratios before the first and second injection of hCG (0.31 ± 0.04 and 0.29 ± 0.04), the mean 17-OHP to T ratio 24 h after the second injection (0.60 ± 0.06, 2.3 ± 0.3 times baseline) was significantly higher (P < 0.02) than (Smals et al. 1980a,b) . This finding was interpreted to indicate a transient blockade in the A4 biosynthetic pathway at the 17,20-lyase.
In this study it was shown that a second injection of hCG 7 days after the first, disclosed patterns of plasma 17-OHP and T levels in two ways different from those after the priming dose: 1) the basal 17-OHP and T levels were significantly reduced by about 20% with an almost identical 17-OHP to T ratio, 2) a more pronounced increase of 17-OHP relative to T occurred 24 h after the second hCG injection than after the priming dose, the increase of the 17-OHP to T ratio at that moment being about twice the increase after the first injection of hCG.
Lowered plasma 17-OHP and T levels to equal proportions 7 days after hCG priming point to a long lasting effect of hCG early in the biosynthetic pathway prior to 17-OHP. Glass & Vigersky (1980) very recently reported a similar lowering of plasma T levels 10 days after a priming dose of hCG in normal men. These investigators however, did not find similarly decreased 17-OHP levels. They con¬ cluded therefore from their data that the block in the conversion of 17-OHP into T still persisted after 10 days. Scrutinizing the data of Glass (Chasalow et al. 1979 ). Lack of receptor availability resulting in decreased pregnenolone formation (Cigorraga et al. 1978; (Valladares & Payne 1979) or enhanced direct testicular secretion might also account for the more pronounced 17-OHP accumulation relative to T after renewed hCG administration. Preliminary data from our laboratory of almost similar circulating oestradiol levels both before and after the priming dose and the second injection of hCG however do not favour such a hypothesis.
